Biosorption of mercury from aqueous solutions using highly characterised peats by A.M. Rizzuti, F.L. Ellis, L.W. Cosme, A.D. Cohen

Get full text

Utilising highly characterised peats to remove cadmium from aqueous solutions by A.M. Rizzuti, K.D. Mouzone, L.W. Cosme, A.D. Cohen

Get full text

Biosorption of hexavalent chromium from aqueous solutions using highly characterised peats by A.M. Rizzuti, C.R. Newkirk, K.A. Wilson, L.W. Cosme, A.D. Cohen

Get full text

Reduced binding of Pittsburgh Compound-B in areas of white matter hyperintensities by A.E. Goodheart, E. Tamburo, D. Minhas, H.J. Aizenstein, E. McDade, B.E. Snitz, J.C. Price, C.A. Mathis, O.L. Lopez, W.E. Klunk, A.D. Cohen

Get full text

Impact of prolonged dose delays on response with belantamab mafodotin (belamaf; gsk2857916) treatment in dreamm-2 study: 13-month follow-up by A. Medaglia, A.D. Cohen, H.C. Lee, S. Trudel, A-O. Abdallah, N. Callander, E. Libby, L. Karlin, S. Lonial, L. Womersley, J. Baron, E. Lewis, K. Nungesser, I. Gupta, J. Opalinska

Get full text

P961: CILTACABTAGENE AUTOLEUCEL, A BCMA-DIRECTED CAR-T CELL THERAPY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: 2-YEAR POST LPI RESULTS FROM THE PHASE 1B/2 CARTITUDE-1... by Y. Lin, T. Martin, J. G. Berdeja, A. Jakubowiak, M. Agha, A. D. Cohen, A. Deol, M. Htut, A. Lesokhin, N. C. Munshi, E. O’Donnell, C. C. Jackson, T.-M. Yeh, A. Banerjee, E. Zudaire, D. Madduri, C. Zhou, L. Pacaud, S. Z. Usmani, S. Jagannath

Get full text

P959: CILTACABTAGENE AUTOLEUCEL IN LENALIDOMIDE-REFRACTORY PATIENTS WITH PROGRESSIVE MULTIPLE MYELOMA AFTER 1-3 PRIOR LINES OF THERAPY: CARTITUDE-2 BIOLOGICAL CORRELATIVE ANALYSES... by J. Hillengass, A. D. Cohen, M. Delforge, H. Einsele, H. Goldschmidt, K. Weisel, M.-S. Raab, C. Scheid, J. M. Schecter, K. C. De Braganca, H. Varsos, T.-M. Yeh, P. Mistry, T. Roccia, C. Corsale, M. Akram, L. Pacaud, T. Nesheiwat, M. Agha, Y. C. Cohen

Get full text

S185: CARTITUDE-2 COHORT B: UPDATED CLINICAL DATA AND BIOLOGICAL CORRELATIVE ANALYSES OF CILTACABTAGENE AUTOLEUCEL IN PATIENTS WITH MULTIPLE MYELOMA AND EARLY RELAPSE AFTER INITIAL... by M. E. Agha, N. W. van de Donk, A. D. Cohen, Y. C. Cohen, S. Anguille, T. Kerre, W. Roeloffzen, J. M. Schecter, K. C. De Braganca, H. Varsos, P. Mistry, T. Roccia, E. Zudaire, C. Corsale, M. Akram, D. Geng, T Nesheiwat, L. Pacaud, P. Sonneveld, S. Zweegman

Get full text

B09 CARTITUDE-2 COHORT B 18-MONTH FOLLOW-UP: CILTACABTAGENE AUTOLEUCEL (CILTA-CEL), A BCMA-DIRECTED CAR-T CELL THERAPY, IN PATIENTS WITH MULTIPLE MYELOMA (MM) AND EARLY RELAPSE AFT... by S. Zweegman, M. Agha, A.D. Cohen, Y.C. Cohen, S. Anguille, T. Kerre, W. Roeloffzen, D. Madduri, J.M. Schecter, K.C. De Braganca, C.C. Jackson, H. Varsos, P. Mistry, T. Roccia, X. Xu, K. Li, E. Zudaire, C. Corsale, M. Akram, D. Geng, L. Pacaud, P. Sonneveld, N. van de Donk

Get full text

P28 EFFICACY AND SAFETY OF CILTACABTAGENE AUTOLEUCEL (CILTA-CEL) IN PATIENTS WITH PROGRESSIVE MULTIPLE MYELOMA (MM) AFTER EXPOSURE TO NON-CELLULAR ANTI-B-CELL MATURATION ANTIGEN (B... by N. van de Donk, M.-V. Mateos, Y.C. Cohen, P. Rodriguez-Otero, B. Paiva, A.D. Cohen, T. Martin, A. Suvannasankha, D. Madduri, C. Corsale, J.M. Schecter, K.C. De Braganca, C.C. Jackson, H. Varsos, W. Deraedt, T. Roccia, P. Mistry, X. Xu, K. Li, E. Zudaire, M. Akram, L. Pacaud, I. Avivi, J. San-Miguel

Get full text

Dreamm-2: single-agent belantamab mafodotin in patients with relapsed/refractory multiple myeloma (rrmm), including subgroups with renal impairment (ri) and high-risk (hr) cytogen... by S. Lonial, H.C. Lee, A. Badros, S. Trudel, A.K. Nooka, A. Chari, A-O. Abdallah, N.S. Callander, D.W. Sborov, A. Suvannasankha, K. Weisel, P.M. Voorhees, M. Hultcrantz, E.N. Libby, P.G. Richardson, P. Rodriguez Otero, B. Besemer, T. Facon, A. Hoos, J. Baron, T. Piontek, R.C. Jewell, E. Lewis, J. Opalinska, I. Gupta, A.D. Cohen, A. Medaglia

Get full text